Cargando…

Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: A meta-analysis

BACKGROUND: To assess the association between hypoglycemic agents and prognosis of lung cancer patients with diabetes. METHODS: A comprehensive literature search was performed in PubMed, Web of Science, Embase, and Cochrane Library until May 2017. The search yielded 2593 unique citations, of which 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xin, Wen-Xiu, Fang, Luo, Fang, Qi-Lu, Zheng, Xiao-Wei, Ding, Hai-Ying, Huang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851744/ https://www.ncbi.nlm.nih.gov/pubmed/29489653 http://dx.doi.org/10.1097/MD.0000000000010035

Ejemplares similares

The Effect of Diabetes Mellitus on Lung Cancer Prognosis: A PRISMA-compliant Meta-analysis of Cohort Studies
por: Zhu, Linhai, et al.
Publicado: (2016)

Adverse events risk associated with anti-VEGFR agents in the treatment of advanced nonsmall-cell lung cancer: A meta-analysis
por: Gu, Biao, et al.
Publicado: (2016)

The effects of physical activity on physiological markers in breast cancer survivors: A meta-analysis
por: Kang, Xin-Yao, et al.
Publicado: (2020)

Diabetes mellitus carries a risk of esophageal cancer: A meta-analysis
por: Xu, Bo, et al.
Publicado: (2017)

Upregulation of tissue long noncoding RNA X inactive specific transcript predicts poor postoperative survival in patients with non-small cell lung cancer
por: Fang, Hengxiao, et al.
Publicado: (2020)

The prognostic effect of metastasis patterns on overall survival in organ metastatic lung adenocarcinoma
por: Tie, Xiaowei, et al.
Publicado: (2022)

Effect of mu Agonists on Long-Term Survival and Recurrence in Nonsmall Cell Lung Cancer Patients
por: Wang, Kai, et al.
Publicado: (2015)

Maintenance treatment of combination with bevacizumab vs single agent for advanced non-squamous non-small cell lung cancer: A systematic review and meta-analysis
por: Kong, Ying, et al.
Publicado: (2021)

Nomogram to predict overall survival and disease-specific survival with appendiceal mucinous adenocarcinoma
por: Yan, Qian, et al.
Publicado: (2019)

Association of diabetes mellitus with thyroid cancer risk: A meta-analysis of cohort studies
por: Li, Hongtao, et al.
Publicado: (2017)

Osimertinib or EGFR-TKIs/chemotherapy in patients with EGFR-mutated advanced nonsmall cell lung cancer: A meta-analysis
por: Huang, Lei, et al.
Publicado: (2019)

Menopausal status and the risk of lung cancer in women: A PRISMA-compliant meta-analysis
por: Min, Lingfeng, et al.
Publicado: (2017)

EGFR-TKIs versus taxanes agents in therapy for nonsmall-cell lung cancer patients: A PRISMA-compliant systematic review with meta-analysis and meta-regression
por: An, Na, et al.
Publicado: (2016)

Clinicopathological and prognostic significance of circRNAs in lung cancer: A systematic review and meta-analysis
por: Zheng, Yuxuan, et al.
Publicado: (2021)

Long-term survival of advanced lung adenocarcinoma by maintenance chemotherapy followed by EGFR-TKI: A case report
por: Chen, Hui Jun, et al.
Publicado: (2021)

A meta-analysis on the relationship of exosomes and the prognosis of lung cancer
por: Xiang, Hui, et al.
Publicado: (2021)

Efficacy of Addition of Antiangiogenic Agents to Taxanes-Containing Chemotherapy in Advanced Nonsmall-Cell Lung Cancer: A Meta-Analysis and Systemic Review
por: Sheng, Jin, et al.
Publicado: (2015)

Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients
por: Shen, Hong, et al.
Publicado: (2016)

Elevated pretreatment neutrophil-to-lymphocyte ratio indicate low survival rate in apatinib-treated patients with non-small cell lung cancer: A STROBE-compliant article
por: Wan, Ya-Nan, et al.
Publicado: (2022)

Efficacy of immune checkpoint inhibitors in the treatment of non-small cell lung cancer patients with different genes mutation: A meta-analysis
por: Zhang, Rui, et al.
Publicado: (2021)

Circulating 25-hydroxyvitamin D and lung cancer risk and survival: A dose–response meta-analysis of prospective cohort studies
por: Feng, Qianqian, et al.
Publicado: (2017)

Simultaneous development of pneumonitis and autoimmune diabetes secondary to immune checkpoint inhibitor treatment with durvalumab in an advanced small cell lung cancer patient: A case report
por: Wen, Yan-Ping, et al.
Publicado: (2022)

Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis
por: Xu, Ya-Ping, et al.
Publicado: (2015)

Diabetes mellitus affects long-term survival in hepatitis B virus-related hepatocellular carcinoma patients: A propensity score-matched analysis
por: Zhang, Haili, et al.
Publicado: (2021)

Prognostic significance of TRIM59 for cancer patient survival: A systematic review and meta-analysis
por: Wang, Min, et al.
Publicado: (2019)

The prognostic value of B7-H4 in pancreatic cancer: Systematic review and meta-analysis
por: Chen, Xin, et al.
Publicado: (2018)

Relationship between marital status and survival in patients with lung adenocarcinoma: A SEER-based study
por: Wu, Ying, et al.
Publicado: (2022)

Chinese herbal medicine for small cell lung cancer patients: A protocol for a systematic review and meta-analysis
por: Mi, Xue, et al.
Publicado: (2020)

The role of antiangiogenic agents in the treatment of gastric cancer: A systematic review and meta-analysis
por: Lei, Xuefen, et al.
Publicado: (2017)

The relationship between CHRNA5/A3/B4 gene cluster polymorphisms and lung cancer risk: An updated meta-analysis and systematic review
por: Yi, Xingxu, et al.
Publicado: (2021)

Survival Prediction Model Using Clinico-Pathologic Characteristics for Nonsmall Cell Lung Cancer Patients After Curative Resection
por: Wu, Ching-Yang, et al.
Publicado: (2015)

A Bayesian network analysis of immunotherapy and taxane chemotherapy as second- or later-line treatments in non-small cell lung cancer
por: Liu, Xin-Xiu, et al.
Publicado: (2022)

Expression of estrogen receptor beta and overall survival in non-small cell lung cancer patients: Protocol for a systematic review and meta-analysis of cohort studies
por: Chen, Haisheng, et al.
Publicado: (2019)

Long-term survival and prognostic implications of patients with invasive breast cancer in southern Taiwan
por: Wu, Shih-Chung, et al.
Publicado: (2020)

Lung and bone metastases patterns in osteosarcoma: Chemotherapy improves overall survival
por: Tang, Liyuan, et al.
Publicado: (2023)

Neoadjuvant therapy of cetuximab combined with chemoradiotherapy in rectal cancer: A single-arm meta-analysis of noncomparative clinical studies and randomized controlled trials
por: Yan, Qi, et al.
Publicado: (2021)

Association between TGF-β1 rs1982073/rs1800469 polymorphism and lung cancer susceptibility: An updated meta-analysis involving 7698 cases and controls
por: Chen, Guangyuan, et al.
Publicado: (2019)

Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma
por: Shen, Hong-Yu, et al.
Publicado: (2023)

The efficacy and safety of platinum plus gemcitabine (PG) chemotherapy with or without molecular targeted agent (MTA) in first-line treatment of non-small cell lung cancer (NSCLC)
por: Yang, Jiaying, et al.
Publicado: (2016)

Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis
por: Revilla-Pacheco, Francisco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ml7gaun69mh7bagcbiv8tfaefm